Get the Stockscreener App
0.8561
1.60%
-0.0139
After Hours:
.86
0.0039
+0.46%
Predictive Oncology Inc stock is traded at $0.8561, with a volume of 171.97K.
It is down -1.60% in the last 24 hours and up +8.30% over the past month.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
See More
Previous Close:
$0.87
Open:
$0.87
24h Volume:
171.97K
Relative Volume:
0.88
Market Cap:
$8.75M
Revenue:
$1.52M
Net Income/Loss:
$-13.97M
P/E Ratio:
-0.2807
EPS:
-3.05
Net Cash Flow:
$-13.29M
1W Performance:
+12.66%
1M Performance:
+8.30%
6M Performance:
-47.15%
1Y Performance:
-8.71%
1-Day Range:
$0.8188
$0.87
1-Week Range:
$0.71
$0.9425
52-Week Range:
$0.55
$3.06
Predictive Oncology Inc Stock (POAI) Company Profile
Name
Predictive Oncology Inc
Sector
Industry
Phone
412-432-1500
Address
91 43RD STREET, PITTSBURGH, MN
Compare POAI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
POAI
Predictive Oncology Inc
|
0.8561 | 8.89M | 1.52M | -13.97M | -13.29M | -3.05 |
|
VEEV
Veeva Systems Inc
|
280.61 | 44.94B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
73.78 | 12.44B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
65.13 | 11.90B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.89 | 7.56B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.08 | 6.19B | 906.14M | -52.62M | 89.62M | -0.3621 |
Predictive Oncology Inc Stock (POAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Initiated | H.C. Wainwright | Buy |
Predictive Oncology Inc Stock (POAI) Latest News
Predictive Oncology reports $2M loss in Q2, faces Nasdaq delisting and merger lawsuit - The Business Journals
Predictive Oncology Reports Significant Losses Amid Financial Challenges - TipRanks
Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Predictive Oncology's ChemoFx Test Could End Trial-and-Error Cancer Treatment as Company Eyes Global Expansion - Stock Titan
Predictive Oncology Surges 17.8% on Intraday Rally: What’s Fueling the Volatility? - AInvest
Predictive Oncology POAI Q2 2025 Earnings Preview Upside Potential Amid Innovations in Predictive Models - AInvest
Predictive Oncology Inc. Hits Oversold Level on RSI IndicatorDaily Stock Market Swing Alerts Highlight Key Movers - beatles.ru
What institutional investors are buying Predictive Oncology Inc. stockMaximize gains with proven stock analysis - Jammu Links News
Is it the right time to buy Predictive Oncology Inc. stockCapitalize on momentum stocks early - Jammu Links News
Is Predictive Oncology Inc. stock overvalued or undervaluedDynamic investment growth - Jammu Links News
What makes Predictive Oncology Inc. stock price move sharplyDynamic investment opportunities - Jammu Links News
What is the risk reward ratio of investing in Predictive Oncology Inc. stockExtraordinary performance - Jammu Links News
How does Predictive Oncology Inc. generate profit in a changing economyAchieve breakthrough financial results - Jammu Links News
Published on: 2025-08-03 19:32:36 - Jammu Links News
Why is Predictive Oncology Inc. stock attracting strong analyst attentionAchieve breakthrough financial results - Jammu Links News
What are analysts’ price targets for Predictive Oncology Inc. in the next 12 monthsFree Stock Market Knowledge Sharing - Jammu Links News
What are the latest earnings results for Predictive Oncology Inc.Breakthrough wealth creation - Jammu Links News
How volatile is Predictive Oncology Inc. stock compared to the marketBest Dividend Review For Consistent Profits - Jammu Links News
How many analysts rate Predictive Oncology Inc. as a “Buy”AI Powered Tips For 2025 - Jammu Links News
Is Predictive Oncology Inc. still worth holding after the dipGrowth Focused Entry Plan Suggestions Issued - metal.it
Published on: 2025-07-29 15:08:31 - metal.it
Predictive Oncology Inc. Outperforms Peers on Volume MetricsOversold Recovery Opportunity Stocks Attract Buyers - metal.it
Published on: 2025-07-28 16:48:14 - beatles.ru
Predictive Oncology Inc. Volume Confirms Breakout — Analysts BullishReliable Alerts for Daily Stock Movers Released - metal.it
Published on: 2025-07-28 14:14:10 - metal.it
What are Predictive Oncology Inc. company’s key revenue driversGet expert advice on portfolio optimization - Jammu Links News
Does Predictive Oncology Inc. stock perform well during market downturnsConsistent double returns - Jammu Links News
When is Predictive Oncology Inc. stock expected to show significant growthInvest confidently with advanced analysis tools - Jammu Links News
Predictive Oncology Inc. Company’s Quarterly Earnings Growth: What the Numbers SayExpert Trading Flow - metal.it
Is Predictive Oncology Inc. a Top Dividend Stock to Watch in 2025Consistent Growth Alert - metal.it
Predictive Oncology Granted Nasdaq Compliance Extension - The Globe and Mail
What analysts say about Predictive Oncology Inc. stockDynamic investment opportunities - PrintWeekIndia
What drives Predictive Oncology Inc. stock priceExtraordinary performance - Autocar Professional
Predictive Oncology Inc. Stock Analysis and ForecastHigh-octane investment gains - jammulinksnews.com
Is Predictive Oncology Inc. a good long term investmentGame-changing capital returns - jammulinksnews.com
Predictive Oncology Inc Stock (POAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.70%
7.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):